Tetrous
PrivateLast Round
Seed Round
Apr 8, 2026
Est. Valuation
$31.5M
Total Funding Raised
$7.59M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tetrous operates in Healthcare & Life Sciences and is based in Sherman Oaks, California. Its latest recorded funding round was a Series A round in March 2025.
Tetrous is a therapeutic devices company that provides regenerative medicine solutions for tissue repair in sports medicine applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tetrous Comparables
Compare Tetrous with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atreon Orthopedics | 83% | |
| Isto Biologics | 77% | |
| Medtronic | 74% |
For institutional investors. Book with your work email.
Tetrous Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 8, 2026 | ||||
| Series A | Mar 10, 2025 | ||||
| Seed | Dec 12, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tetrous Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ABT Healthcare | Series A |
| Australian Biotechnologies | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 16, 2026
Grew 50% QoQ, from 10 to 15 employees.
- Jul 17, 2026
Grew 56% QoQ, from 9 to 14 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 13, 2026
Tetrous, Inc. begins a controlled commercial launch of EnFix, a demineralized bone fiber device portfolio designed to support healing at the bone-to-tendon interface, in Australia and the United States in Jul '23 with seven surgeons.
For institutional investors. Book with your work email.
Tetrous Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tetrous's valuation, stock price, and market status.
Is Tetrous a public or private company?
Tetrous is a private company.
What is the current stock price of Tetrous?
Tetrous is a private company, so its shares have no public market price. Caplight tracks Tetrous's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tetrous worth (valuation)?
Tetrous's valuation is estimated at $31.5M based on funding round data.
Can I buy Tetrous stock?
Tetrous shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tetrous's last funding round?
Tetrous's most recent funding round was Seed Round on April 8, 2026.
Who are the main investors in Tetrous?
Key investors in Tetrous include ABT Healthcare, Australian Biotechnologies.
Will Tetrous IPO soon?
No public IPO plans have been announced for Tetrous.
How can I track Tetrous secondary market activity?
Caplight tracks bids, offers, and trades in Tetrous's shares on secondary markets.